09-12-2025 20:35 via medpagetoday.com

Bispecific Trial in Myeloma Sparks Talks of 'Functional Cure'

(MedPage Today) -- ORLANDO--Combining teclistamab (Tecvayli) with subcutaneous daratumumab-hyaluronidase (Darzalex Faspro) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with relapsed/refractory...
Read more »

Medical news



RFK Jr. Tops This Year's Shkreli Awards
Should Congress Intervene in the Newborn Hep B Vaccine Controversy?
Triplet Delays Breast Cancer Progression in First-Line Maintenance Setting
Gender Care Docs Accused of Fraud; Army Ob/Gyn Criminally Charged; Nurse Sentenced
U.S. Suicide Rate Fell in 2024 After Hovering at High Level
Gene Therapy-Induced CAR T Cells for Myeloma Could Alter Treatment Landscape
Outbreak Hospitalizes 51; Cardiologist Attacked; Birth in a Self-Driving Car
One Antidepressant Deprescribing Strategy Topped Others in Preventing Relapse
Next-Gen SERD Cuts Breast Cancer Recurrence Risk by 30% in Trial
New York Times Says It Won't Be Deterred From Writing About Trump's Health
How Do We Know Aluminum Adjuvants in Vaccines Are Safe?
Partisan Politics Sidetrack House Hearing on Healthcare Tech Costs
Gene Therapy Wins FDA Approval for Life-Threatening Immunodeficiency
House Democrat Files Articles of Impeachment Against RFK Jr.
Desktop versie